1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Milagen, Inc. - Product Pipeline Analysis, 2016 Update

Milagen, Inc. - Product Pipeline Analysis, 2016 Update

  • February 2016
  • -
  • Global Data
  • -
  • 21 pages

Summary

Milagen, Inc. (Milagen) is a medical device company that offers diagnostic products. The company discovers, develops and markets non-invasive immunodiagnostic products for monitoring, surveillance and detection of cancers. It provides immunohistochemistry products and cytology products including antibodies to confirm cervical dysplasia, and preservative reagents for cervical cell and smear collection. Milagen also offers products such as tissue-based in vitro diagnostic assays and serum-based IVD assays. The company’s proprietary biomarkers are used for the early detection of cancer, colon cancer, prostate cancer, ovarian cancer and pancreatic cancer. It operates through institutions and medical centers. Milagen is headquartered in Emeryville, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Milagen, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

Milagen, Inc. - Product Pipeline Analysis, 2016 Update
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Milagen, Inc. Company Snapshot 5
Milagen, Inc. Company Overview 5
Key Information 5
Milagen, Inc. Pipeline Products and Clinical Trials Overview 6
Milagen, Inc. - Major Products and Services 8
Milagen, Inc. Pipeline Products by Development Stage 9
Milagen, Inc. Pipeline Products Overview 11
Immunoassay - Breast Cancer 11
Immunoassay - Breast Cancer Product Overview 11
Immunoassay - Cervical Cancer 12
Immunoassay - Cervical Cancer Product Overview 12
Immunoassay - Colon Cancer 13
Immunoassay - Colon Cancer Product Overview 13
Immunoassay - Lung Cancer 14
Immunoassay - Lung Cancer Product Overview 14
Immunoassay - Ovarian Cancer 15
Immunoassay - Ovarian Cancer Product Overview 15
Immunoassay - Pancreatic Cancer 16
Immunoassay - Pancreatic Cancer Product Overview 16
Immunoassay - Prostate Cancer 17
Immunoassay - Prostate Cancer Product Overview 17
Milagen, Inc. - Key Competitors 18
Milagen, Inc. - Key Employees 19
Milagen, Inc. - Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Milagen, Inc., Key Facts 5
Milagen, Inc. Pipeline Products and Clinical Trials Overview 6
Milagen, Inc. Pipeline Products by Equipment Type 6
Milagen, Inc. Pipeline Products by Indication 7
Milagen, Inc., Major Products and Services 8
Milagen, Inc. Number of Pipeline Products by Development Stage 9
Milagen, Inc. Pipeline Products Summary by Development Stage 10
Immunoassay - Breast Cancer - Product Status 11
Immunoassay - Breast Cancer - Product Description 11
Immunoassay - Cervical Cancer - Product Status 12
Immunoassay - Cervical Cancer - Product Description 12
Immunoassay - Colon Cancer - Product Status 13
Immunoassay - Colon Cancer - Product Description 13
Immunoassay - Lung Cancer - Product Status 14
Immunoassay - Lung Cancer - Product Description 14
Immunoassay - Ovarian Cancer - Product Status 15
Immunoassay - Ovarian Cancer - Product Description 15
Immunoassay - Pancreatic Cancer - Product Status 16
Immunoassay - Pancreatic Cancer - Product Description 16
Immunoassay - Prostate Cancer - Product Status 17
Immunoassay - Prostate Cancer - Product Description 17
Milagen, Inc., Key Employees 19

List of Figures
Milagen, Inc. Pipeline Products by Equipment Type 7
Milagen, Inc. Pipeline Products by Development Stage 9

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2016

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • July 2016
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Granulocyte ...

Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline Review, H2 2016

Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • July 2016
  • by Global Markets Direct

Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Macrophage Colony ...

VolitionRX Ltd. (VNRX) - Product Pipeline Analysis, 2016 Update

VolitionRX Ltd. (VNRX) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • July 2016
  • by Global Data

Summary VolitionRX Ltd. (VolitionRX) is a life science company that develops diagnostic solutions. The company develops blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.